Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

The doctor is a leading gastroenterologist in South Korea and Asia, specializing in the management of pancreatic, bile duct, and gallbladder cancers, as well as pancreatitis and gallstones.

Currently practicing at Samsung Medical Center, the doctor has an educational background from The Seoul National University College of Medicine and The University of California.

The doctor is an active member of several professional organizations, including The Korean Society of Gastrointestinal Endoscopy, The Korean Society of Gastroenterology, and The Korean Pancreatobiliary Association.

The doctor is a top gastroenterologist specializing in the management of pancreatic, bile duct, and gallbladder cancers. With extensive experience, the doctor serves as a gastroenterology specialist at the Department of Gastroenterology at Samsung Medical Center.

The doctor completed medical education at Hanyang University College of Medicine in South Korea, with further training at Stanford University School of Medicine in the USA and Kyoto Second Red Cross Hospital in Japan. The doctor is also an active member of The Korean Society of Gastrointestinal Endoscopy and The Korean Society of Gastroenterology.

Urologist, Oncosurgeon

The doctor is an accomplished oncogynecologist with extensive experience in treating gynecological cancers. Specializing in advanced surgical techniques and personalized treatment plans, the doctor has contributed significantly to improving patient outcomes. With numerous publications in peer-reviewed journals, the doctor is recognized for expertise in minimally invasive procedures and has been a keynote speaker at international conferences.

The doctor holds board certification in gynecologic oncology and is actively involved in clinical research, focusing on innovative therapies and early detection methods. The doctor is affiliated with a leading medical institution and collaborates with multidisciplinary teams to provide comprehensive care.

The doctor is a highly experienced oncologist with a focus on innovative cancer treatment methodologies. With over 15 years of clinical practice, the doctor has successfully treated a wide range of malignancies using cutting-edge therapies and personalized medicine approaches. The doctor is board-certified and has contributed to numerous peer-reviewed publications in oncology journals. Additionally, the doctor has been involved in several groundbreaking research projects aimed at improving patient outcomes and has presented findings at international conferences.

The doctor is a highly skilled gynecologist with a specialized focus in oncogynecology, providing expert care in the diagnosis and treatment of gynecological cancers. With extensive experience in both surgical and non-surgical approaches, the doctor is committed to advancing women's health through innovative treatments and compassionate care.

The doctor is an accomplished oncosurgeon with extensive experience in urology. As the Head of the Samsung Department of Urology, the doctor has led numerous innovative surgical procedures and contributed to significant advancements in the field. The doctor is recognized for expertise in minimally invasive techniques and has been instrumental in developing new protocols for cancer treatment. The doctor is highly regarded for a commitment to patient care and has received multiple accolades for contributions to medical research and education.